LRTM3
gene geneOn this page
Also known as FLJ40176
Summary
LRTM3 (leucine rich repeat transmembrane protein 3, HGNC:26851) is a protein-coding gene on chromosome 13q33.1, encoding Leucine-rich repeat transmembrane protein 3 (Q8NDH2).
Predicted to be located in membrane.
Source: NCBI Gene 643677 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 677 total
- MANE Select transcript:
NM_001146197
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26851 |
| Approved symbol | LRTM3 |
| Name | leucine rich repeat transmembrane protein 3 |
| Location | 13q33.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ40176 |
| Ensembl gene | ENSG00000175820 |
| Ensembl biotype | protein_coding |
| Entrez | 643677 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000322527
RefSeq mRNA: 1 — MANE Select: NM_001146197
NM_001146197
CCDS: CCDS73596
Canonical transcript exons
ENST00000322527 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001224565 | 102729367 | 102750388 |
| ENSE00003713915 | 102758410 | 102758452 |
| ENSE00003724621 | 102758543 | 102758576 |
| ENSE00003737691 | 102758702 | 102759072 |
Expression profiles
Bgee: expression breadth broad, 15 present calls, max score 98.48.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0254 / max 23.4564, expressed in 4 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 138107 | 0.0254 | 4 |
Top tissues by expression
237 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 98.48 | gold quality |
| buccal mucosa cell | CL:0002336 | 85.89 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.35 | gold quality |
| left testis | UBERON:0004533 | 71.98 | gold quality |
| right testis | UBERON:0004534 | 71.20 | gold quality |
| testis | UBERON:0000473 | 70.44 | gold quality |
| colonic epithelium | UBERON:0000397 | 52.43 | gold quality |
| ventricular zone | UBERON:0003053 | 49.74 | gold quality |
| bone marrow cell | CL:0002092 | 49.45 | gold quality |
| adult organism | UBERON:0007023 | 48.98 | silver quality |
| ganglionic eminence | UBERON:0004023 | 48.53 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 48.53 | silver quality |
| skin of hip | UBERON:0001554 | 46.13 | silver quality |
| sural nerve | UBERON:0015488 | 46.00 | gold quality |
| lower lobe of lung | UBERON:0008949 | 45.07 | silver quality |
| middle temporal gyrus | UBERON:0002771 | 44.65 | gold quality |
| apex of heart | UBERON:0002098 | 44.48 | silver quality |
| bone marrow | UBERON:0002371 | 43.38 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| cortical plate | UBERON:0005343 | 43.30 | gold quality |
| liver | UBERON:0002107 | 43.22 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 43.07 | gold quality |
| muscle tissue | UBERON:0002385 | 42.80 | gold quality |
| cauda epididymis | UBERON:0004360 | 42.79 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| right atrium auricular region | UBERON:0006631 | 41.63 | silver quality |
| cardiac atrium | UBERON:0002081 | 41.58 | silver quality |
| islet of Langerhans | UBERON:0000006 | 41.44 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.13 |
Regulation
Is transcription factor: no
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ccdc168 | ENSMUSG00000091844 |
Protein
Protein identifiers
Leucine-rich repeat transmembrane protein 3 — Q8NDH2 (reviewed: Q8NDH2)
Alternative names: Coiled-coil domain-containing protein 168
All UniProt accessions (1): Q8NDH2
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
RefSeq proteins (1): NP_001139669* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031624 | CCDC168_N | Domain |
| IPR053366 | LRR_transmembrane | Family |
Pfam: PF15804
UniProt features (86 total): compositionally biased region 23, region of interest 22, repeat 20, sequence variant 15, sequence conflict 4, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
No AlphaFold model available for Q8NDH2 — AlphaFold DB does not currently provide models for proteins above ~3000 aa.
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 12 (showing top):
ID2_TARGET_GENES, ZNF664_TARGET_GENES, chr13q33, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN, GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP, GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN, GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_UP, GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN, GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP, FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP, FLORIO_HUMAN_NEOCORTEX, GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
300 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LRTM3 | ZNF563 | Q8TA94 | 503 |
| LRTM3 | RNF223 | E7ERA6 | 489 |
| LRTM3 | FBF1 | Q8TES7 | 459 |
| LRTM3 | VPS33A | Q96AX1 | 458 |
| LRTM3 | SLC17A9 | Q9BYT1 | 457 |
| LRTM3 | A0A2R8YFG2 | A0A2R8YFG2 | 453 |
| LRTM3 | MEAF6 | Q9HAF1 | 452 |
| LRTM3 | FSIP2 | Q5CZC0 | 435 |
| LRTM3 | ASTE1 | Q2TB18 | 431 |
| LRTM3 | RBM5 | P52756 | 425 |
| LRTM3 | CLCN3 | P51790 | 416 |
| LRTM3 | ADGRV1 | Q8WXG9 | 415 |
| LRTM3 | EXOSC10 | Q01780 | 410 |
| LRTM3 | PTK6 | Q13882 | 408 |
| LRTM3 | RUVBL2 | Q9Y230 | 405 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CCDC168 | H1-5 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CCDC168 | HSPA5 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ESYT2 | psi-mi:“MI:0914”(association) | 0.350 | |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| BMI1 | MEIS3P1 | psi-mi:“MI:0914”(association) | 0.350 |
| CYBB | CYBA | psi-mi:“MI:0914”(association) | 0.350 |
| MST1R | SHTN1 | psi-mi:“MI:2364”(proximity) | 0.270 |
ESM2 similar proteins: A0A1B0GTH6, A0A1D5RMD1, A1KXM5, A2AEY4, A6NCI8, A6QQS3, A7KBS4, C4P6S0, O94713, P0C9Z7, P53963, P53976, Q0P670, Q0VAV2, Q10668, Q196W1, Q2KHR3, Q2YDJ5, Q32MG2, Q3V0A6, Q3V3Q4, Q4V8E9, Q5JRM2, Q68FV4, Q6AXV6, Q6AYN3, Q6NS59, Q7TSG5, Q80VJ6, Q80Y39, Q80YD3, Q810T2, Q86XD8, Q8C5U4, Q8CH19, Q8IWI9, Q8K4E0, Q8NDH2, Q8NEV8, Q8NFU7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
677 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 568 |
| Likely benign | 95 |
| Benign | 12 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
311 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 13:102758539:TTA:T | donor_loss | 1.0000 |
| 13:102758540:TAC:T | donor_loss | 1.0000 |
| 13:102758541:A:AC | donor_gain | 1.0000 |
| 13:102758542:C:CG | donor_gain | 1.0000 |
| 13:102750384:CAACT:C | acceptor_gain | 0.9900 |
| 13:102750387:CT:C | acceptor_gain | 0.9900 |
| 13:102750389:C:CC | acceptor_gain | 0.9900 |
| 13:102758541:AC:A | donor_gain | 0.9900 |
| 13:102758542:CC:C | donor_gain | 0.9900 |
| 13:102758542:CCA:C | donor_gain | 0.9900 |
| 13:102758542:CCAA:C | donor_gain | 0.9900 |
| 13:102758542:CCAAG:C | donor_gain | 0.9900 |
| 13:102750386:ACTC:A | acceptor_loss | 0.9800 |
| 13:102750388:TCTGA:T | acceptor_loss | 0.9800 |
| 13:102750389:C:A | acceptor_loss | 0.9800 |
| 13:102750390:T:A | acceptor_loss | 0.9800 |
| 13:102750385:AACT:A | acceptor_gain | 0.9700 |
| 13:102750386:ACT:A | acceptor_gain | 0.9700 |
| 13:102750387:CTC:C | acceptor_gain | 0.9700 |
| 13:102750388:TCT:T | acceptor_gain | 0.9700 |
| 13:102758577:C:CC | acceptor_gain | 0.9700 |
| 13:102750276:TAG:T | donor_gain | 0.9600 |
| 13:102758700:ACCT:A | donor_gain | 0.9600 |
| 13:102758701:CCTC:C | donor_gain | 0.9600 |
| 13:102750389:C:G | acceptor_gain | 0.9500 |
| 13:102758453:C:CC | acceptor_gain | 0.9500 |
| 13:102758577:C:CA | acceptor_loss | 0.9500 |
| 13:102758539:TTACC:T | acceptor_loss | 0.9400 |
| 13:102758696:TCTTA:T | donor_loss | 0.9400 |
| 13:102758697:CTTA:C | donor_loss | 0.9400 |
AlphaMissense
46999 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000141080 (13:102754196 C>G,T), RS1000390675 (13:102748125 G>A,T), RS1000420057 (13:102731500 C>A,T), RS1000745031 (13:102742695 C>A,G), RS1000999156 (13:102749802 A>G), RS1001023680 (13:102730153 T>A), RS1001031421 (13:102736807 C>T), RS1001107864 (13:102743449 A>C,G), RS1001303159 (13:102755703 A>G,T), RS1001326788 (13:102730559 T>A,G), RS1001492843 (13:102748500 C>T), RS1001504279 (13:102748268 T>C), RS1001508719 (13:102735213 A>G), RS1001571010 (13:102756112 C>T), RS1001712782 (13:102741703 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| versicolorin A | increases expression | 1 |
| coumarin | decreases phosphorylation | 1 |
| tebuconazole | decreases expression | 1 |
| Benzo(a)pyrene | increases mutagenesis | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.